Research Papers

25 of 136019 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Multidisciplinary approach and treatment of acral and mucosal melanoma.
Fortuna A; Amaral T.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay.
Zhang H; Chen N; Ding C; Zhang H; Liu D; Liu S.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A FACS-based novel isolation technique identifies heterogeneous CTCs in oral squamous cell carcinoma.
Chauhan A; Pal A; Sachdeva M; Boora GS; Parsana M; Bakshi J; Verma RK; Srinivasan R; Chatterjee D; Maitra A; Ghoshal S.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia.
Schmid VK; Hobeika E.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
<i>In vitro</i> and <i>in vivo</i> modeling systems of supratentorial ependymomas.
Hatanaka EA; Breunig JJ.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Solid pseudopapillary neoplasm of the pancreas: a retrospective study of 195 cases.
Fu C; Li X; Wang Y; Wang C; Jin H; Liu K; Xu H.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Machine Learning-Based Nomogram for Predicting Overall Survival in Elderly Patients with Cirrhotic Hepatocellular Carci…
Qiao W; Sheng S; Li J; Jin R; Hu C.
J Hepatocell Carcinoma (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Prediction of prognosis in oral squamous cell carcinoma using infrared microspectroscopy.
Whitley CA; Ellis BG; Triantafyllou A; Gunning PJ; Gardner P; Barrett SD; Shaw RJ; Smith CI; Weightman P; Risk JM.
Unknown Journal
Published: 2024
4/6 Transparent
Data Funding Declared
Causal associations between atrial fibrillation and breast cancer: A bidirectional Mendelian randomization analysis.
Gong Z; Hu M; Yang Y; Yin C.
Unknown Journal
Published: 2024
4/6 Transparent
Data Funding Declared
Combination tumor-treating fields treatment for patients with metastatic non-small cell lung cancer: A cost-effectivene…
Liu K; Zhu Y; Zhu H; Zeng M.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Cell morphology best predicts tumorigenicity and metastasis in vivo across multiple TNBC cell lines of different metast…
Conner SJ; Guarin JR; Le TT; Fatherree JP; Kelley C; Payne SL; Parker SR; Bloomer H; Zhang C; Salhany K; McGinn RA; Henrich E; Yui A; Srinivasan D; Borges H; Oudin MJ.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer.
Yang F; Yuan C; Chen F; Qin ZS; Schmitt NC; Lesinski GB; Saba NF; Teng Y.
Unknown Journal
Published: 2024
4/6 Transparent
Data Funding Declared
Molecular probes targeting HER2 PET/CT and their application in advanced breast cancer.
Gao F; Liu F; Wang J; Bi J; Zhai L; Li D.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Virtual follow-up care among breast and prostate cancer patients during and beyond the COVID-19 pandemic: Association w…
Bender JL; Scruton S; Wong G; Abdelmutti N; Berlin A; Easley J; Liu ZA; McGee S; Rodin D; Sussman J; Urquhart R.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Comprehensive analysis indicated that NDE1 is a potential biomarker for pan-cancer and promotes bladder cancer progress…
Wang P; Ning J; Chen W; Zou F; Yu W; Rao T; Cheng F.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic.
Smith KL; Mead-Harvey C; Mazza GL; Shinn EH; Frank ES; Melisko ME; Eaton C; Liu Y; Salamone JM; Pollastro T; Spears PA; Caston NE; Wolff AC; Rocque GB.
Unknown Journal
Published: 2024
4/6 Transparent
Data Funding Declared
Multi‑parameter quantitative magnetic resonance imaging in the early assessment of radiation‑induced parotid damage in …
Zhang X; Xu Z; Jin Y; Huang L; Wu W; Gao M.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Liquid biopsy utilizing miRNA in patients with advanced breast cancer treated with cyclin‑dependent kinase 4/6 inhibito…
Kubeczko M; Tudrej P; Tyszkiewicz T; Krzywon A; Oczko-Wojciechowska M; JarzĄb M.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The landscape of 8q24 cytoband in gastric cancer (Review).
Larios-Serrato V; Valdez-Salazar HA; Ruiz-Tachiquín ME.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Association between the MDR1 rs1045642 polymorphism and breast cancer risk: An updated meta‑analysis.
Gong L; Hu G; Xu L; Chen Y; Wang N.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Influence of Zika virus on the cytotoxicity, cell adhesion, apoptosis and inflammatory markers of glioblastoma cells.
Marinowic DR; Zanirati GG; Azevedo PN; Zanatta Â; Plentz I; Alcará AM; Morrone FB; Scheffel TB; Cappellari AR; Roehe PM; Muterle Varela AP; Machado DC; Spillari Viola F; Da Costa JC.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Identification and prognostic analysis of ferroptosis‑related gene HSPA5 to predict the progression of lung squamous ce…
Guo D; Feng Y; Liu P; Yang S; Zhao W; Li H.
Oncol Lett (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
A meta‑ and bioinformatics analysis of maspin expression levels influencing the prognosis of patients with breast cance…
Shi S; Zhang ZG; Sang YZ; Sun J; Ma HY.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
The Clinical and Pathological Characteristics of POLE-Mutated Endometrial Cancer: A Comprehensive Review.
Yao X; Feng M; Wang W.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemoth…
Li W; Zheng Z; Wang J; Wu T; Wang J; Pan Y; Chen J; Hu D; Xu L; Zhang Y; Chen M; Zhou Z.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared